Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider's series D round.
Ascension Ventures, an investment fund representing 13 healthcare providers in the United States, contributed to a $260m series D round for US-based medical device developer Imperative Care yesterday.
Investment firm D1 Capital Partners led the round, which included private equity firm Bain Capital’s Life Sciences subsidiary as well as HealthCor Investments, Innovatus Capital Partners, Ally Bridge Group, Delos Capital, Rock Springs Capital and Amed Ventures.
Imperative Care was spun off from medical technology accelerator Incept in 2015 and produces medical…
